Mountain Group Partners closes third fund at more than $128 million
Nashville-headquartered Mountain Group Partners last week announced the closing of an above target amount of $128 million in its third fund, appropriately named MGP Fund III. With the new capital, Mountain Group will continue its strategy of investing in early stage companies within human and animal life sciences and disruptive technologies.
“We are extremely pleased with the support received from our existing and new investors for MGP Fund III and look forward to continuing to build businesses that improve the lives of others,” said Joe Cook, III, Managing Director at Mountain Group. Founded in 2002, Mountain Group says that it takes a unique, hands-on approach to venture investing based on the deep operational experience of the Firm’s Partners.
Within life sciences, Mountain Group focuses on opportunities in diagnostics, medtech, and drug development across human and animal health. The firm’s technology strategy predominantly targets companies in healthcare information technology and business services. The firm has already made five investments from MGP Fund III including two in the fast-growing animal health sector.
Click here to read last week’s news release.
